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Background: Alopecia is a dermatological disorder with psychosocial implications on patients with hair loss. Hair
loss is one of the most feared side effects of chemotherapy. Plants have been widely used for hair growth promotion
since ancient times in Ayurveda, Chinese and Unani systems of medicine. The effect of extracts of Cuscuta reflexa Roxb.
in testosterone induced alopecia was reported.
Objective: In the present study, the efficacies of the extracts of Cuscuta reflexa in promoting hair growth in
cyclophosphamide-induced hair loss have been determined.
Materials and methods: The study was performed by treated with petroleum ether and ethanolic extract of Cuscuta
reflexa at the dose 250 mg/kg in male swiss albino rats. Cyclophosphamide (125 mg/kg) was used to induce alopecia.
Results: Groups treated with extracts of plant showed hair regrowth. Histopathology and gross morphologic
observations for hair regrowth at shaved sites revealed active follicular proliferation.
Conclusions: It concluded that extracts of Cuscuta reflexa shown to be capable of promoting follicular proliferation or
preventing hair loss in cyclophosphamide-induced hair fall.
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Hair is a major esthetic display feature of the human
body, especially in social and sexual interactions. Several
drugs have an effect on hair growth and some bring
about hair loss, the clinical symptoms of which are the
results of interaction between the drugs and various cells
important for hair growth. Such cells include follicular
keratinocytes, cells of the hair matrix, peri-follicular blood
vessels and those of the connective tissues surrounding
the hair bulbs. The keratinocytes are a major target for the
toxic effect of environmental agents or xenobiotics. This
may be because up to 90% of all hair follicles are in a
phase of rapid growth and the high rate of blood flow
around hair bulbs results in a good bioavailability of many
drugs at these sites [1].
The three major and frequent toxicities of cytotoxic
cancer chemotherapy are bone marrow suppression,
gastrointestinal disturbances and alopecia. Induction of
massive hair loss (alopecia) by many chemotherapeutic* Correspondence: vkdixit2011@rediffmail.com
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reproduction in any medium, provided the ordrugs ranks among the most psychologically devastating
side effects of cancer treatment. More than 80% of
patients who receive chemotherapy consider hair loss
the most distressing aspect of their treatment [2,3].
There have been remarkable advances in the under-
standing of the molecules and pathways regulating hair
follicle formation, hair growth and hair loss [4,5]. Similarly,
many products are now in the market for promoting hair
growth and treating hair loss. However, these products
often lack significant clinical efficacy in preventing the hair
loss effect of chemotherapy.
Cuscuta reflexa Roxb. (Family Cuscutaceae), known as
“amarvela” in vernacular, is a parasite, with slender yellow
stems. It is widespread in temperate and tropical regions
and common found throughout India. It grows on differ-
ent host plants [6,7]. Traditionally, it used in treatment of
protracted fever, diaphoretic, and as demulcent and as
purgative [8,9]. Recent studies by Roy et al. [10,11] showed
that extract and formulation of extract of C. reflexa Roxb.
with Citrullus colocynthis Schrad. and Eclipta alba Hassk.
have hair growth promoting activity and enhanced the
regrowth of hair at shaved site. Similar results observedd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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petroleum ether extract of C. reflexa [12]. In the present
study, the efficacies of extracts of C. reflexa in counteracting
cyclophosphamide (CYP) induced hair loss were investi-
gated. The findings of this experiment might stimulate
the development of a new, effective therapy for hair loss
especially in patients undergoing chemotherapy.
Materials and methods
Plant material
Long yellow stems of Cuscuta reflexa growing on
Bougainvillea spectabilis and Jasminum multiforum
were collected in the month of Oct-Nov 2010 from
forests surrounding our university campus, Sagar and
were authenticated by Dr. P.K Tiwari, Department of
Botany, Dr. H.S.Gour University (Herbarium no. Bot/
Her/2123). The whole stem were firstly sun dried for
5–8 days and then finally dried in an oven at 35-40°C for
48 h. The dried stems were ground into coarse powders.
Extraction
Coarsely powdered materials were extracted with petrol-
eum ether (60–80°C) until complete extraction in soxhlet
apparatus. The solvent from the extract was eliminated
under reduced pressure (yield 3.0% w/w). The marc
obtained after petroleum ether extraction was subjected
to ethanol (95%) extraction in soxhlet apparatus for
10–16 h at 70-80°C. The solvent from the extract was
eliminated under reduced pressure (yield 3.6% w/w).
Chemicals
Cyclophosphamide (CYP) was purchased from Himedia
Laboratories (Mumbai, India). Tween 80, Petroleum ether
and ethanol were all from Sigma-Aldrich (India).
Test samples
Cyclophosphamide (CYP) solution (125 mg/kg body
weight) was prepared in distilled water. Petroleum ether
extract suspension (250 mg/kg body weight) was pre-
pared with help of tween-80. Ethanolic extract solution
(250 mg/kg body weight) was prepared in distilled water.
Distilled water use as a vehicle.
Animal
Twenty-Four male Swiss albino rats (3-4months age,
120-140 g) were used for experiments. The animals were
housed in standard cages with free access to food and
water. The animal house temperature was maintained at
23 ± 1°C with a 12 hour light and12 hour dark cycle.
The Institutional Ethical Committee of Dr H.S. Gour
University (Reg. No. 319/01/ab/CPCSEA) approved the
protocol of all animal experimentation. The guidelines
of CPCSEA, India were strictly followed.Grouping of animals
The animals were randomly divided in 4 groups of 6
male Swiss albino rats and were treated as follows:
Group I: Vehicle only (Distilled water) (Control).
Group II: CYP solution (125 mg/Kg) (i.p.) (Negative
control).
Group III: CYP solution (125 mg/Kg) (i.p.) + Petroleum
ether extract solution (250 mg/Kg) of C. reflexa (orally).
Group IV: CYP solution (125 mg/Kg) (i.p.) + Ethanolic
extract solution (250 mg/Kg) of C. reflexa (orally).
Cyclophosphamide (CYP) induced Alopecia
Cyclophosphamide is one of the most often used anti-
cancer drugs. During chemotherapy, alopecia is inducing
because of follicle dystrophy and/or the premature induc-
tion of follicle regression (catagen) in growing (anagen)
hair follicles. The back skins of rats were depilated of hair.
This was done so that, at the start of pharmacological
manipulation, all hair follicles in the depilated back skin
area of all rats were in exactly the same stage of anagen
development (predictable and highly synchronized anagen
development can only be achieved with anagen induction
by depilation, as opposed to spontaneous anagen devel-
opment). As soon as anagen VI stage (after 9–10 day of
depilation) reached, all the rats of test groups injected
once with a high dose of CYP. Extract solutions were
orally administered on 2nd day after CYP administered.
At different time, points after CYP injection, selected rat
was sacrificed to correlate visible hair phenomena with
a histological profile of follicle response and recovery
(morphometry) [13].
Anagen induction
Male Rats had gone through several postnatal hair cycles
were induce to enter anagen by depilation of all hair
shaft (having any cycle). It was done by applying hair
remover to back skin and by peeling off this mixture
after some time [14]. By this technique, all depilated
hair follicles immediately start in on to transform into
anagen follicles (Stage-I to Stage -VI) with their associated
properties. After 9–10 days of depilation, they enter in
Anagen -VI stage.
Induction of Alopecia
As soon as early anagen-VI stage reached by induced
anagen follicles, i.e. on day 9th post depilation, a single
intraperitoneal injection of CYP was given (125 mg/kg
body weight, freshly dissolved in distilled water).
Treatment of animals for study
The method reported by Paus was followed with slight
modification. Rats in-group II, group III and group IV
were administered cyclophosphamide intraperitoneally
(125 mg/kg body weight) once i.e. on 9th day of depilation.
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petroleum ether extract of Cuscuta reflexa and ethanolic
extract of C. reflexa respectively from the day next to CYP
administration upto 19 day of study. Animals of group I
were treated with vehicle only. After 19th days of study, rat
from each group was selected randomly and sacrificed.Observation
The difference in growth of hair in each group was noticed
by visual observation and was recorded by taking photo-
graphs (Figure 1A,B,C,D). Skin biopsy as well undertaken
from the depilation site of each group of rat, and samples
of skin were kept in phosphate-buffered formalin for paraf-
fin sectioning. Vertical sections (3–4 μm) were cut parallel
to the direction of hair growth and stained with haematoxy-
lin and eosin. The cyclic phase of hair follicles (anagen and
telogen), number of hair follicles and the anagen/telogen




Figure 1 Comparison of baldness pattern in each group. (A) Animal tr
CYP showing diffused alopecia. (C) Animal treated with CYP and Pet ether
ethanolic extract showing less hair loss. a: After Depilation, b: After 9th DayFindings
Morphologic observation
Feed and water intake did not vary significantly in Group-
I animals throughout the study period. Hair re-growth at
shaved sites became obvious within 2–4 days after shaving.
Shaved sites were about mostly covered by day 14 and hair
texture and volume compared well with unshaved areas
by day 19 (Figure 1A).
In the animals of Group-II, in the first 9 days of study,
they had normal feeding pattern. After CYP adminis-
tration during 10-12th day of study, they had normal
feeding pattern but from 15th day, an appreciable drop
in feeding rate was observed. Hair growth at depilated
site was visibly inhibited in most of the animals by day
14th after an initial tiny growth. After 19th day of study
hair loss was significant at depilated sites in all the
animals. The hairs on other parts of the animals generally





eated with Vehicle only showing No hair loss (B) Animal treated with
extract showing less hair loss. (D) Animal treated with CYP and
of study (CYP Administered) c: After 19th Day of study.
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the feeding pattern. Hair regrowth at depilated site was
slow upto 14th day and on 19th day of study, full regrowth
was observed. There was very little sign of alopecia
(Figure 1C).
In animals of Group-IV, there were no significant vari-
ations in the feeding pattern. Hair regrowth at depilated
site was not observed at 14th day. After 14th day little
hair regrowth started. Hair regrowth at depilated site
was visible in 80% of animal after 19th day of study.
Some animal show the sign of alopecia (Figure 1D).
Histological observation
Histopathological observation in animals of group-I re-
vealed focal areas of hypergranulosis, normal hair folli-
cles and numerous maturing hair follicles (Figure 2A). In
Group-II, skin of animal showed disruption of melanin
granules, irregular banding pattern of hair shaft, disrup-
tion of epidermis, less number of hair follicles, irregular
diameters of hair bulbs, wide open hair canal and dis-
tortion of hair follicles (Figure 2B). In Group-III, skin
of animals showed normal epidermis, more number of
hair follicles, wide open hair canal, both anagen and
telogen cycle observed, melanin granules not distributed
irregularly as in group-II, less distortion of hair follicle,
regular diameter of hair follicles, hair shaft and fragments
present (Figure 2C). Histopathologically, skin of group
IV animal showed thickened and regular epidermis, less
number of hair follicles, distorted hair follicles also present
along with normal hair follicles, wide open hair canal,
irregular diameter of hair follicle, few hair shaft fragments
observed, melanin granules not distributed (Figure 2D).
Hair density
The histological study showed that hair density was
maximum i.e. 3.75 ± 0.62 in case of vehicle treated, 2.5 ±
0.79 in case of petroleum ether extract of Cuscuta
reflexa treated, 2.33 ± 0.88 in case of ethanolic extract of
C. reflexa treated, while it was minimum i.e. 2.08 ± 0.79
in control (CYP) treated animals.
Anagen telogen ratio (A/T ratio)
The histological study showed that A/T ratio was max-
imum i.e. 3.20:1 in case of vehicle treated, 1.70:1 in case of
petroleum ether extract of C. reflexa treated, 1.43:1 in case
of ethanolic extract of C. reflexa treated, while it was mini-
mum i.e. 1:2.83 in control (CYP) treated animals.
Number of anagen follicles in treated group show
following order:
Group I > Group III > Group IV > Group II.
Number of telogen follicles in treated group show
following order:
Group II > Group IV > Group III > Group I.Discussion
Cancer treatment with chemotherapeutic agents is as-
sociated with severe side effects due to the occurrence
of apoptosis in several sensitive tissues (such as the
hematopoietic system or epithelia of digestive tract)
because of drug cytotoxicity [15]. This apoptosis largely
depends on p53, a key mediator of cellular mechanism
of stress response [16]. p53 accumulation in sensitive cells
after a variety of stresses results in growth arrest at one
of the cellular checkpoints or induction of programmed
cell death [17]. Cancer chemotherapy disrupts the pro-
liferation of matrix keratinocytes in the anagen bulb
that produce the hair shaft. This induced anagen follicles
to enter a dystrophic catagen stage in which the integrity
of the hair shaft is compromised and the hair breaks
and falls off [18]. A significant number of hair follicles
are in anagen at any one time. These hairs are, however,
rapidly lost during chemotherapy. CYP administration will
result in enhanced deterioration of the matrix, leading to
premature catagen formation and thus increased telogen
shedding [19]. When administered in higher doses, CYP
was found to inhibit mitosis in the hair bulb, leading to
narrowing of the hair shaft, which subsequently breaks
at this point. Apoptosis of hematopoietic cells and
cells of the digestive tract associated with cancer treat-
ment is recognized to be p53 dependent. Radiation- or
chemotherapy-induced DNA damage leads to the rapid
accumulation of p53 protein in the susceptible cells
[17,20], followed by up-regulation of Fas, IGF-BP3, and
Bax, encoded by the corresponding p53-responsive
genes. Moreover, it was demonstrated that Fas and Bax
are up regulated in the HF during cyclophosphamide
treatment [4].
Many chemotherapeutic agents are strongly affecting
hair follicles by because of the rapid proliferative rate
of hair matrix keratinocytes during anagen. In the rat
model of chemotherapy induced hair loss, the active
hair growth phase was first induced by depilation, and
cyclophosphamide administration during new anagen
phase causes complete alopecia imitating changes seen
in human chemotherapy induced hair loss. The drug
treatment induces dystrophic changes in growing HF
and, in more severely damaged follicles, premature
regression because of massive apoptosis in the entire
proximal hair bulb, with subsequent hair shedding
[13,21].
The decrease in feed/water consumption especially in
animals that received only CYP is due to adverse systemic
effects of CYP.
Petroleum ether extract and ethanolic extract of Cuscuta
reflexa showed the ability to prevent damage to hair folli-
cles by CYP when administered after CYP administration
and enhanced hair regrowth. Therefore, C. reflexa have










Figure 2 Histology of skin sections. (A) Skin of animal treated with Vehicle only (B) Skin of animal treated with CYP. (C) Skin of animal treated
with CYP and Pet ether extract solution. (D) Skin of animal treated with CYP and ethanolic extract solution. (HF: Hair Follicle).
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induced alopecia. They possibly will be act by preventing
accumulation or downregulation of p53 a key mediator of
cellular mechanism of stress response. p53 accumulation
in sensitive cells after a variety of stresses results in growth
arrest at one of the cellular checkpoints or induction of
programmed cell death. Thus preventing the apoptosis of
hair follicles, dystrophic changes in growing hair follicle
and preventing hair loss.Conclusion
In this work it was to be concluded that the petroleum
ether extract and ethanolic extract of Cuscuta reflexa
were use to prevent hair loss or to treat the alopecia (a
common side effect in the cancer treatment) during
chemotherapy.Competing interests
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